I am proud to announce our new BLOG Post Series, titled “LIVING Your Legend” in honor of celebrating 20 years of living the mission.
I am proud to announce our new BLOG Post Series, titled “LIVING Your Legend” in honor of celebrating 20 years of living the mission.
This month’s CURE MAG Cover Tip brought to you by the End Brain Cancer Initiative, and through our patient advocacy and disease education partnership with CURE, focuses on Glioblastoma Multiforme (GBM).
Navigating care for patients with cancer can be overwhelming considering the multiple specialists they encounter and the numerous decisions they must make. For patients with GBM management is further complicated by a poor prognosis, feelings of isolation, urgency to treat, and cognitive decline.
Exciting news from Corporate Partner GT Medical who offer a truly groundbreaking treatment for those undergoing surgery for their brain tumor in the form of safe and effective surgically targeted radiation delivered right to the tumor site.
One of my most favorite things to do under my leadership of the EndBrainCancer Initiative is to talk directly to patients with brain cancer and to hear first hand, “their story” and to “see” with my own eyes as well as to “hear” with my own ears how they IMPACT others.
Today, May 31, 2020, the very last day of #BTAM month, I find myself reflecting on many things and just looked through the photos from last year’s Bellingham Brain Cancer WALK (BBCW), and am smiling and crying at the same time.
Discover the inspiring story behind the 2020 National HOPE Award, honoring brain tumor patients who inspire with courage and resilience during their journey.
WEBINAR! COVID-19 & BRAIN CANCER! Important information on how COVID-19 affects Brain Cancer (and other cancer) patients. Join Al Musella of the Musella Foundation and Dr. Eric T. Wong, Brain Tumor Center & Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center and Harvard Medical School.
Dellann Elliott Mydland announces a new book she is writing to tell her story, and invites members of the public to share stories of tragedy in life where personal tragedy was transformed into actions and impact for good to help others.
On August 7, the Centers for Medicare & Medicaid Services (CMS) finalized the decision to cover FDA-approved Chimeric Antigen Receptor T-cell, or “CAR T-cell” therapy, which is a form of cancer treatment that uses a patient’s own genetically-modified immune cells to fight disease. FDA-approved CAR T-cell therapies are approved to treat some people with specific types of […]
A gallery of slides which describe how we ignite hope and fuel research.
I am using the word “Advocacy” to refer to my work as it relates to clinical trial development for GBM and rGBM patients. For the past year and half, I have been on the VIGILANT Steering Committee providing a “Patient Voice” for the VIGILANT Trial.